Follow-up contract for fertilizer plant in Hungary awarded to ThyssenKrupp Industrial Solutions

At a glance

ThyssenKrupp Industrial Solutions has secured a follow-up order from Nitrogénmüvek Zrt. to build a nitric acid plant in Hungary. This is the third contract in two years, highlighting customer satisfaction. The new plant will help meet the growing demand for food by increasing agricultural productivity and saving resources.

ThyssenKrupp Industrial Solutions, the engineering and construction specialist of the ThyssenKrupp Group, has again won a follow-up order from the Hungarian fertilizer manufacturer Nitrogénmüvek Zrt. to expand its production capacity. A 1,150 ton per day nitric acid plant is to be built at Pétfürdö, around 100 kilometers southwest of Budapest. The contract value is in the high double digit million euro region. Completion is scheduled for 2017.
Nitrogénmüvek Zrt. already operates two ammonium nitrate plants supplied by ThyssenKrupp Industrial Solutions at the Pétfürdö site. A plant to manufacture granulated calcium ammonium nitrate (CAN) and ammonium nitrate fertilizer is currently under construction. ThyssenKrupp Industrial Solutions is responsible for engineering, procurement, construction, installation and commissioning of the new nitric acid plant.
Dr. Hans Christoph Atzpodien, CEO of ThyssenKrupp Industrial Solutions: “We are delighted at this third contract from Nitrogénmüvek Zrt. in only two years and at the greatly increased scope compared with the previous orders. This is a sign of great satisfaction on the part of our customer and validation of our strategy of offering engineering, procurement and construction from a single source.”
The world’s population is growing rapidly, and with it the demand for food. Raising agricultural productivity is therefore an important factor in satisfying the rising demand despite limited arable land. “Our highly efficient fertilizer plants make an important contribution to raising productivity and saving resources in the production of staple foods,” says Dr. Hans Christoph Atzpodien.